secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2026-08-31T21:21:41+00:00
Accession:  0001193125-26-377073
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jazz closes $1.25B exchangeable notes offering; repurchases $225M shares
------------------------------------------------------------------------

- Completed $1.25B 1.875% exchangeable senior notes due 2032, including full $150M greenshoe exercise.
- Net proceeds estimated at ~$1,226.4M; intended for general corporate purposes.
- Initial exchange rate 2.8150 shares per $1,000 principal; exchange price ~$355.24 (42.5% premium).
- Concurrently repurchased ~$225M of ordinary shares at $249.29 via private transactions.
- Notes mature Sept 15, 2032; fully and unconditionally guaranteed by Jazz on senior unsecured basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/0001193125-26-377073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/d127542d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-377073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer